38
Participants
Start Date
October 1, 2015
Primary Completion Date
May 13, 2016
Study Completion Date
May 13, 2016
Shigella flexneri 2a InvaplexAR
The investigational product is S. flexneri 2a InvaplexAR. The product is composed of three individual components IpaB, IpaC, and LPS. The components were assembled into the high molecular weight S. flexneri 2a InvaplexAR complex and subsequently purified by ion-exchange chromatography yielding a bulk lot.
Walter Reed Army Institute of Research, Clinical Trials Center, Silver Spring
U.S. Army Medical Research and Development Command
FED